Decoy Therapeutics Inc. (DCOY) Shareholders’ equity 2015–2022
Decoy Therapeutics Inc. (DCOY) shareholders’ equity at each fiscal year-end, per SEC filings.
$10.4MFY2022 · since FY2015: $92.2M → $10.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $10.4M | -73.2% |
| FY2021 | $38.7M | +74.7% |
| FY2020 | $22.2M | +109.4% |
| FY2019 | $10.6M | +932.4% |
| FY2018 | -$1.3M | +56.2% |
| FY2017 | -$2.9M | -104.9% |
| FY2016 | $59.3M | -35.7% |
| FY2015 | $92.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice